Navigation Links
Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance
Date:7/28/2009

results, adjusted for the effects of the acceleration of the Preferred Stock dividend at the beginning of the period, is more reflective of the Company's current diluted operating results and provides investors with additional useful information to measure the Company's on-going performance. Three Months Six Months Ended Ended June 30, June 30, Income Statement as a % of Net Sales: 2009 2008 2009 2008 Net sales 100.0% 100.0% 100.0% 100.0% Cost of goods sold - materials 30.4% 30.5% 30.3% 30.1% Personnel costs 34.0% 34.0% 35.8% 36.0% Other operating expenses 21.2% 21.4% 20.8% 20.9% Depreciation and amortization 1.9% 2.4% 2.3% 2.5% Income from operations 12.5% 11.8% 10.8% 10.5% Interest expense 3.9% 4.4% 4.2% 4.8% Unrealized gain from interest rate swap 0.1% 0.0% 0.1% 0.0% Income before taxes 8.7% 7.4% 6.7% 5.7% Provision for income taxes 3.5% 3.0% 2.7% 2.3% Net income 5.2% 4.4% 4.0% 3.4%

                              Hanger Orthopedic Group, Inc.
                                      (Unaudited)

                                      Three Months Ended    Six Months Ended
                                           June 30,              June 30,
    Cash Flow Data:                   2009          2008     2009      2008

    Cash flow from operations       $24,475        $20,026  $20,760  $12,569
    Capital expenditures             $3,271         $4,750   $6,097   $7
'/>"/>
SOURCE Hanger Orthopedic Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Hanger Orthopedic Group, Inc. Announces Second Quarter 2009 Earnings Release Conference Call
2. Hanger Orthopedic Group, Inc. Receives Upgrade from Standard & Poors Rating Services
3. Hanger Orthopedic Group, Inc. Announces Two Acquisitions Totaling $5.3 Million of Annual Net Revenue
4. Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009
5. Hanger Orthopedic Group, Inc. Announces First Quarter 2009 Earnings Release Conference Call
6. Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
7. Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer
8. Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue
9. Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call
10. Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students
11. Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...David Kim of the Live Life Again Center, a practic... of a growing number of physicians who are taking...onnect with individuals who are interested in surg.... Dr. Kim is utilizing Facebook to share before-an...with the community. , Dal...
(Date:11/26/2009)...on Communications announces a highly effective and...rs struggling to make an economic recovery. , ...Flu fears is the type of challenge that could send...ding to Dr. David Benton, business growth expert a...stem – The Rfactor Intensive . “Fea...
(Date:11/25/2009)...ewswire-USNewswire/--WhenmostpeopleheartheacronymT...givepatientsthehelptheyneed.TMJstandsfortheTempora...tacts/connectswithyourskull(temporalbone). ,, T...epainwithchewing,clickingorpoppingofthejaw.Butmany...g:headaches,fatigue,sleepdisturbances,irritability...
(Date:11/25/2009)...25/PRNewswire-FirstCall/-- OnyxPharmaceuticals,In...osttwoinvestoreventsinDecember: ,, ASHBriefin... ,, Principalinvestigatorswilldiscussdataprese...actorymultiplemyeloma,asfeaturedatthe51stAmericanS...nNewOrleans,LA.Theteleconferencewillbeginat9:00a.m...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...and,Industries, Inc. (NYSE: HB ) today announced ...per share. This dividend was declared by Hillenbra...s payable on March 31, 2008 to,shareholders of rec...s,serving the health care and funeral services ind...
...e likely to make mistakes , , FRIDAY, Feb...depressed are about six times more likely to make ... says a study that looked a 123 pediatric resident...out. During the study period, the residents made a...
...JPS Enterprises, LLC, (http://www.cjps-enterprises... to,facilitate the marketing and licensing of inte...LC (http://www.TechTransferOnline.com ) is alread...,to fill the shelves of the store before you open ...
...3 Program of CGT-2168, MENLO PARK, Calif., Feb. 8...tinguished international panel of medical experts ...ged with overseeing COGENT,the company,s global Ph...OGO ), The panel includes experts in the fields o...
...SE: MYL ),today announced that Mylan Pharmaceutic...ive law judge in Florida finding that the inclusio...drug formulary is an invalid,exercise of legislati...soon,as motions and procedural steps surrounding i...
...althcare,Acquisition Corp. (AMEX: MBH ), a public...ounced today that it will host an investor,confere...Eastern time to,discuss the recently announced sig...rom MBH will be Mike Fernandez,Chairman and CEO, J...
Other Medicine News:Health News:Depression in Young Doctors Tied to Medication Errors 2Health News:CJPS Enterprises Spins Off New Company for Intellectual Property Marketing 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 3Health News:Mylan Restores Availability of Generic Levothyroxine in Florida 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4
(Date:11/25/2009)... NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannou...talogue: ,, IntranasalDrugDelivery-USMarketTre...4267/Intranasal-Drug-Delivery---US-Market-Trends--...rketiswitnessinganexpansionoftherapeuticapplicatio...gstothedeliveryofsystemictherapeuticdrugs.Thefutur...
(Date:11/25/2009)... MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCe...tafromtheCompany,sPROTECT-1(theProspectiveRandomiz...ficet-EN(TM)(CCX282-B)inpatientswithmoderate-to-se...afavorablesafetyandtolerabilityprofile.Thestudydem...fdiseaseseverityasdefinedasa70-pointdecreaseintheC...
(Date:11/24/2009)... IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/--Endol...ivetreatmentsforaorticdisorders,announcedtodaythat...sin,thepatentinfringementlawsuitbroughtagainstitin...StatesDistrictCourtinIndianapolis,Indiana. ,, E...theUnitedStatesPatentandTrademarkOffice(USPTO)cond...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 10052 1Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 10052 2Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 10052 3First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 1First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 2Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 1Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 2Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 3
...EY, April 24 HeartWare International, Inc. (Nasda...ults for its international clinical trial of the H...esults were presented by Dr. Martin Strueber, card...the annual meeting of the International Society fo...aris this week. A full copy of the presentation wa...
...ers at Tufts Medical Center have created a formula...with certain genetic profiles and lifestyle behavi...neration (AMD), a potentially blinding condition t...er Americans and is increasing dramatically as the...M. Seddon, MD, ScM, Professor of Ophthalmology at ...
Other Medicine Technology:HeartWare International Clinical Trial Shows 90% Survival at 180 Days 2HeartWare International Clinical Trial Shows 90% Survival at 180 Days 3Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD) 2
Ocuvite® Lutein Eye Vitamin and Mineral Supplements
...ext-generation dietary supplement from the invento...s the root inflammatory cause and effects of dry e...rature that these specific nutrients support norma... of the body, such as mucous membranes of the mout...
Unity Desktop
Vision Premier Holter System
Medicine Products: